Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2025-11-18 Audit Report / Informat…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
114年第3季財務報告書 — 202504_1795_AIA.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'Consolidated Financial Statements With Independent Auditors’ Report For the Years Ended December 31, 2025 and 2024' and contains detailed financial statements including balance sheets, income statements, cash flows, notes, and an independent auditor's opinion. It includes extensive audit details, key audit matters, and management responsibilities, which are typical components of a full audit report accompanying consolidated financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, this document fits the category of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or other categories. FY 2025
2025-11-18 Chinese
114年第3季財務報告書 — 202504_1795_AI3.pdf
Regulatory Filings
2025-11-18 Chinese
114年第3季財務報告書 — 202504_1795_AI1.pdf
Audit Report / Information Classification · 95% confidence The document is titled as a consolidated financial report and auditor's report for the fiscal years 114 and 113 (Taiwanese calendar years, corresponding to 2025 and 2024). It includes detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, and notes to the financial statements. There is a comprehensive auditor's report with audit opinion, basis of opinion, key audit matters, and responsibilities of management and auditors. The document contains substantive financial data and analysis, not just an announcement or certification. The presence of detailed financial statements and auditor's report indicates this is an Audit Report / Information filing rather than a full Annual Report (10-K) or other categories. The document length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2025
2025-11-18 Chinese
114年第3季財務報告書 — 202503_1795_AIA.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Consolidated Financial Statements' with an 'Independent Auditors’ Review Report' for the nine months ended September 30, 2025 and 2024. It includes detailed consolidated balance sheets, statements of comprehensive income, changes in equity, cash flows, and notes to the financial statements. The report references International Accounting Standard 34, 'Interim Financial Reporting', and the review is conducted under the Standard on Review Engagements 2410, which is typical for interim or quarterly financial reports. The presence of financial data for a nine-month period and the auditor's review report indicates this is an interim or quarterly report rather than a full annual report or standalone audit report. The document length (15,000 characters) and detailed financial data confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2025
2025-11-18 Chinese
114年第3季財務報告書 — 202503_1795_AI1.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Accountant's Review Report". It includes detailed consolidated financial statements such as the balance sheet, income statement, statement of changes in equity, and cash flow statement for the periods ending September 30, 2024 and 2023 (民國114年及113年). The presence of an accountant's review report (核閱報告) indicates this is a reviewed interim or quarterly financial report rather than a full annual report. The document references compliance with International Accounting Standard 34 "Interim Financial Reporting" and includes detailed financial data and notes. The length of the document (15,000 characters) and the detailed financial statements confirm it is a substantive financial report, not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-11-18 Chinese
114年第3季財務報告書 — 202502_1795_AIA.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Consolidated Financial Statements With Independent Auditors’ Review Report For the Six Months Ended June 30, 2025 and 2024' and contains detailed consolidated balance sheets, statements of comprehensive income, changes in equity, cash flows, and notes to the consolidated financial statements. It includes an independent auditor's review report, which explicitly states the review is conducted in accordance with standards for interim financial reporting (International Accounting Standard 34). The document covers a six-month period ending June 30, 2025, which is a period shorter than a full fiscal year. The presence of detailed financial statements and notes confirms this is a comprehensive interim financial report rather than just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-11-18 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.